Literature DB >> 31361426

The economic burden of the opioid epidemic on states: the case of Medicaid.

Douglas L Leslie1, Djibril M Ba, Edeanya Agbese, Xueyi Xing, Guodong Liu.   

Abstract

The societal burden of opioid use disorder (OUD) is considerable and contributes to increased healthcare costs and overdose deaths. However, the burden is not well understood. The purpose of this analysis is to estimate the state Medicaid programs' costs for treating OUD and how these costs have changed over time. We used data from the Medicaid Analytic eXtract files from 17 states between 1999 and 2013 to examine the healthcare costs associated with OUD. Inpatient, outpatient, and prescription medication costs related to the treatment of OUD were included, as were excess costs for other healthcare services (eg, general medical care) for individuals with OUD relative to a comparison group of individuals without OUD matched on age, sex, and state. We then extrapolated our results to the entire US Medicaid population using population-based sample weights. All costs were adjusted for inflation and are reported in 2017 US dollars. During our study period, the number of patients who were diagnosed with OUD increased 378%, from 39,109 (0.21% of total Medicaid enrollment) in 1999 to 186,979 (0.60% of total Medicaid enrollment) in 2013 in our 17-state sample. Even after adjusting for inflation, total Medicaid costs associated with OUD more than tripled during this time, reaching more than $3 billion in 2013, from $919 million in 1999. Most of this growth was due to excess non-OUD treatment costs for patients with OUD, which increased 363% over the period; the rate of growth is triple the expenditures for OUD treatment services. When the results were extrapolated to the entire United States, the Medicaid costs associated with OUD increased from more than $2 billion in 1999 to more than $8 billion in 2013. The total cumulative costs that were associated with OUD for this extrapolated 50-state sample over a 15-year time period amounts to more than $72.4 billion. OUD imposes considerable financial burden on state Medicaid programs, and the burden is increasing over time.

Entities:  

Year:  2019        PMID: 31361426

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  13 in total

1.  Cannabis as a Gateway Drug for Opioid Use Disorder.

Authors:  Arthur Robin Williams
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

2.  The association of prescription opioid use with suicide attempts: An analysis of statewide medical claims data.

Authors:  Chongliang Luo; Kun Chen; Riddhi Doshi; Nathaniel Rickles; Yong Chen; Harold Schwartz; Robert H Aseltine
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

3.  Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.

Authors:  Gerald Cochran; Julie Bruneau; Nicholas Cox; Adam J Gordon
Journal:  Subst Abus       Date:  2020       Impact factor: 3.716

Review 4.  The state of the science in opioid policy research.

Authors:  Megan S Schuler; Sara E Heins; Rosanna Smart; Beth Ann Griffin; David Powell; Elizabeth A Stuart; Bryce Pardo; Sierra Smucker; Stephen W Patrick; Rosalie Liccardo Pacula; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2020-06-27       Impact factor: 4.492

5.  Plan Type and Opioid Prescriptions for Children in Medicaid.

Authors:  Jordan Banks; Courtney Hill; Donald L Chi
Journal:  Med Care       Date:  2021-05-01       Impact factor: 3.178

6.  Data Needs in Opioid Systems Modeling: Challenges and Future Directions.

Authors:  Mohammad S Jalali; Emily Ewing; Calvin B Bannister; Lukas Glos; Sara Eggers; Tse Yang Lim; Erin Stringfellow; Celia A Stafford; Rosalie Liccardo Pacula; Hawre Jalal; Reza Kazemi-Tabriz
Journal:  Am J Prev Med       Date:  2020-12-01       Impact factor: 5.043

7.  Infectious Complications in Injection Drug Use.

Authors:  Ryan Knodle; Lindsay Demers; Rachel Simmons
Journal:  MedEdPORTAL       Date:  2021-03-23

Review 8.  Advances in 3D neuronal microphysiological systems: towards a functional nervous system on a chip.

Authors:  Wesley A Anderson; Alexander Bosak; Helena T Hogberg; Thomas Hartung; Michael J Moore
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-12       Impact factor: 2.416

9.  A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study.

Authors:  Md Mahmudul Hasan; Gary J Young; Jiesheng Shi; Prathamesh Mohite; Leonard D Young; Scott G Weiner; Md Noor-E-Alam
Journal:  BMC Med Inform Decis Mak       Date:  2021-11-26       Impact factor: 2.796

10.  Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis.

Authors:  Georgia C Richards; Kamal R Mahtani; Tonny B Muthee; Nicholas J DeVito; Constantinos Koshiaris; Jeffrey K Aronson; Ben Goldacre; Carl J Heneghan
Journal:  BMC Med       Date:  2020-03-30       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.